More from Archive

More from In Vivo

China’s Medtech Policies Prompt Reflection Among Global Companies As Local Players Adapt

 
• By 

Chinese medtechs are expanding rapidly worldwide, but gaining market access within China itself – poised to become the world’s largest medtech market – is proving to be a very different challenge.

Execs On The Move: September 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

One Year In, Xaira’s Drug Discovery Vision Meets Reality

 
• By 

The billion-dollar startup has doubled headcount, released massive datasets and is advancing therapeutics, but the hard part lies ahead.